Tracking the evolution of an extensively drug-resistant cross-border Mycobacterium tuberculosis cluster, Europe, January 2016 up to August 2025: implications for European surveillance

The emergence and spread of an extensively drug-resistant (XDR) <i>Mycobacterium tuberculosis</i> lineage 4.8 cluster in Europe raises public health concerns. First reported in 2020 across Romania, Italy and the United Kingdom, this cluster progressed from multidrug-resistant (MDR) and pre-extensively drug-resistant (pre-XDR) to XDR, including resistance to pretomanid. Evidence of ongoing local transmission is available for Italy, where 10 cases were reported from 2021 to 2025. Strengthened whole genome sequencing-based surveillance is needed to inform timely, coordinated public health responses.

Authors

Institutions

Publication Details

Journal
Eurosurveillance
Published
2025-11-20
DOI
https://doi.org/10.2807/1560-7917.es.2025.30.46.2500838
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tracking the evolution of an extensively drug-resistant cross-border Mycobacterium tuberculosis cluster, Europe, January 2016 up to August 2025: implications for European surveillance

Chiara Sepulcri, Federico Di Marco, Luca Ragazzoni, Francesca Saluzzo et al.
Eurosurveillance
Tuberculosis Research and Epidemiology
article

Tracking the evolution of an extensively drug-resistant cross-border Mycobacterium tuberculosis cluster, Europe, January 2016 up to August 2025: implications for European surveillance

Chiara Sepulcri, Federico Di Marco, Luca Ragazzoni, Francesca Saluzzo, Luigi Ruffo Codecasa, Marco Rossi, Daniela María Cirillo, Alma Zinola
article en

Abstract

The emergence and spread of an extensively drug-resistant (XDR) <i>Mycobacterium tuberculosis</i> lineage 4.8 cluster in Europe raises public health concerns. First reported in 2020 across Romania, Italy and the United Kingdom, this cluster progressed from multidrug-resistant (MDR) and pre-extensively drug-resistant (pre-XDR) to XDR, including resistance to pretomanid. Evidence of ongoing local transmission is available for Italy, where 10 cases were reported from 2021 to 2025. Strengthened whole genome sequencing-based surveillance is needed to inform timely, coordinated public health responses.

EurosurveillanceVol. 30(46)
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), Vita-Salute San Raffaele University (IT), Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), University of Genoa (IT)
Openalex Percentile: Top 58%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tracking the evolution of an extensively drug-resistant cross-border Mycobacterium tuberculosis cluster, Europe, January 2016 up to August 2025: implications for European surveillance — Chiara Sepulcri, Federico Di Marco, et al. · Eurosurveillance (2025) | TGRS Research Map | TGRS